- Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial. Hainsworth, J.D., Spigel, D.R., Sosman, J.A., Burris, H.A., Farley, C., Cucullu, H., Yost, K., Hart, L.L., Sylvester, L., Waterhouse, D.M., Greco, F.A. Clin. Genitourin. Cancer (2007)